These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27475749)

  • 21. [Autoantibodies in systemic lupus erythematosus: spectrum and clinical associations].
    Haddouk S; Ben Ayed M; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
    Pathol Biol (Paris); 2005 Jul; 53(6):311-7. PubMed ID: 16004941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center.
    Font J; Cervera R; Ramos-Casals M; García-Carrasco M; Sents J; Herrero C; del Olmo JA; Darnell A; Ingelmo M
    Semin Arthritis Rheum; 2004 Feb; 33(4):217-30. PubMed ID: 14978660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
    Hanly JG; Thompson K; McCurdy G; Fougere L; Theriault C; Wilton K
    J Immunol Methods; 2010 Jan; 352(1-2):147-52. PubMed ID: 19836394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
    Haddouk S; Marzouk S; Jallouli M; Fourati H; Frigui M; Hmida YB; Koubaa F; Sellami W; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
    Rheumatology (Oxford); 2009 Aug; 48(8):953-7. PubMed ID: 19502474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
    Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
    Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
    Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
    Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
    Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
    Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
    Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
    Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating Anti-SmD1-amino-acid 83-119 Peptide Reactivity in Children with Systemic Lupus Erythematosus and Other Immunological Diseases.
    Yang HO; Zhang XQ; Fu QH
    Chin Med J (Engl); 2016 Dec; 129(23):2840-2844. PubMed ID: 27900999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
    Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evolution of autoantibodies profile in systemic lupus erythematosus according to age and clinical manifestations].
    Diallo MS; Mbengue B; Seck A; Ndao AC; Niang MS; Cissoko Y; Thiam A; Diop G; Diallo RN; Diallo M; Ndongo S; Dièye TN; Cissé M; Kane A; Dièye A
    Ann Biol Clin (Paris); 2014; 72(3):351-8. PubMed ID: 24876146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.
    Popescu C; Zofotă S; Bojincă V; Ionescu R
    Rom J Intern Med; 2013; 51(3-4):179-87. PubMed ID: 24620631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies.
    Castellino G; Corallini F; Trotta F; Secchiero P
    Lupus; 2007; 16(7):479-82. PubMed ID: 17670845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus.
    Mok CC; Lau CS; Chan TM; Wong RW
    Lupus; 1999; 8(3):188-96. PubMed ID: 10342711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of erosive phenotypes in lupus arthritis using magnetic resonance imaging and anti-citrullinated protein antibody, anti-RA33 and RF autoantibody status.
    Ball EM; Tan AL; Fukuba E; McGonagle D; Grey A; Steiner G; Bell AL; Rooney MR
    Rheumatology (Oxford); 2014 Oct; 53(10):1835-43. PubMed ID: 24850876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between anti-Ro/La titers and clinical findings of patients with systemic lupus erythematosus.
    Chien JW; Lin CY; Yang LY
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 May; 64(5):283-91. PubMed ID: 11499338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.